Table 2.

Details of tumour size, deviation of CST and diffusion metrics

Patient	WHO grade	Classification of motor impairment	Fugl-Meyer test point score	Planar area of largest tumour mass	ID of the CST	FA	MD	AD	RD
1	II	1	63	49	0.23	0.3	0.69	0.9	0.59
2	II	0	66	9	0.14	0.3	1.04	1.35	0.89
3	II	1	64	10	0.08	0.3	0.76	0.98	0.65
4	II	0	66	17	0.16	0.8	0.67	1.43	0.29
5	II	0	66	20	0.07	0.5	0.65	1.05	0.45
6	III	3	50	31	0.14	0.3	0.35	0.64	0.21
7	III	3	45	28	0.23	0.2	1.33	1.58	1.2
8	III	0	66	45	0.13	0.3	0.72	0.92	0.62
9	III	3	51	27	0.06	0.4	0.64	0.88	0.48
10	III	2	58	62	0.38	0.4	0.72	1.08	0.53
11	III	0	66	19	0.11	0.6	0.68	1.14	0.44
12	III	0	66	30	0.11	0.2	0.79	0.98	0.69
13	III	3	40	19	0.00	0.2	1.32	1.56	1.2
14	II	0	66	6	0.09	0.3	0.86	1.25	0.67
15	III	0	66	7	0.09	0.3	1.13	1.48	0.95
16	II	0	66	8	0.11	0.2	0.89	1.1	0.79
17	III	0	66	7	0.05	0.4	1.04	1.48	0.82
Mean from ipsilateral side ± SD				23.2 ± 16.4	0.13 ± 0.8	0.35* ± 0.16	0.84 ± 0.26	1.16 ± 0.28	0.67* ± 0.29
Mean from contralateral side ± SD						0.51 ± 0.15	0.67 ± 0.03	1.08 ± 0.16	0.46 ± 0.08

Classification of motor impairment ranges from “0” = no to “4” = severe motor impairment

Diffusivities are given in units of n ´ 10⁻³ (mm²/s)

Area of tumour is given in (mm²)

FA fractional anisotropy, ID index of deviation, MD mean diffusivity, AD axial diffusivity, RD radial diffusivity, SD standard deviation

^* p _corr < 0.03